CHAMEDITECH held a business meeting with TTL Brazil,
a Brazilian partner in Hyafilia (HA filler) in December 2021.
And we introduced CHA Health System,
an integrated research-oriented platform for industry, academia,
research and disease, and discussed local business in Brazil.
Juliano Victorino (CEO/Trust Group)
who is the CEO of Trust Group,
the parent company of TTL Brazil,
expressed a keen interest in
CHAMEDITECH's research activities and quality control.
Also, they visited the R&D center located in Daejeon
to discuss the status of local authorization in Brazil
and made an appointment to proceed with local authorization quickly.
Trust Group is a local distributor of chemicals,
medicines, and food products in Brazil,
and plans to expand its market share
after completing authorization registration in 2023.